Free Trial

SurgePays (NASDAQ:SURG) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?

SurgePays logo with Computer and Technology background

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.94 and traded as high as $3.07. SurgePays shares last traded at $2.90, with a volume of 118,154 shares changing hands.

Analyst Ratings Changes

A number of research analysts recently commented on SURG shares. Ascendiant Capital Markets upped their price objective on SurgePays from $8.50 to $8.75 and gave the company a "buy" rating in a report on Tuesday, April 22nd. Wall Street Zen upgraded SurgePays from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd.

Read Our Latest Research Report on SurgePays

SurgePays Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 6.24 and a quick ratio of 4.70. The company has a market capitalization of $57.77 million, a price-to-earnings ratio of -2.50 and a beta of 0.51. The stock has a 50 day simple moving average of $2.67 and a two-hundred day simple moving average of $1.95.

SurgePays (NASDAQ:SURG - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The medical equipment provider reported ($0.38) earnings per share for the quarter, beating analysts' consensus estimates of ($0.40) by $0.02. The company had revenue of $10.58 million for the quarter, compared to analysts' expectations of $9.80 million. SurgePays had a negative return on equity of 55.63% and a negative net margin of 27.39%. During the same period last year, the firm earned $0.07 earnings per share. As a group, analysts anticipate that SurgePays, Inc. will post -1.66 earnings per share for the current year.

Hedge Funds Weigh In On SurgePays

Several hedge funds have recently made changes to their positions in SURG. D.A. Davidson & CO. purchased a new position in shares of SurgePays during the first quarter worth about $25,000. Goldman Sachs Group Inc. acquired a new stake in shares of SurgePays during the 1st quarter valued at approximately $28,000. Baader Bank Aktiengesellschaft acquired a new stake in shares of SurgePays during the 1st quarter valued at approximately $35,000. XTX Topco Ltd acquired a new position in shares of SurgePays during the 4th quarter worth approximately $53,000. Finally, Jane Street Group LLC acquired a new position in shares of SurgePays during the 4th quarter worth approximately $54,000. Hedge funds and other institutional investors own 6.94% of the company's stock.

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Recommended Stories

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines